Evaluation and Comparison of Using Low-Dose Aprotinin and Tranexamic Acid in CABG: A Double Blind Randomized Clinical Trial
Low-dose aprotinin and tranexamic acid can significantly reduce blood loss and transfusion requirement in CABG without importantly increasing mortality and morbidity.